Heartflow (HTFL) Cash from Operations (2024 - 2025)
Heartflow's quarterly Cash from Operations came in at 10596000.0 in Q4 2025, up 24.52% year-on-year from 8509533.64 in Q4 2024, and down 258.34% quarter-over-quarter from 2957000.0 in Q3 2025.
Heartflow has reported Cash from Operations for 2 years, with the latest figure at 10596000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Operations rose 24.52% year-over-year to 10596000.0; the trailing twelve-month figure through Dec 2025 stood at 37858000.0 (changed N/A YoY), and the FY2025 full-year result was 54023000.0, up 21.71% from the prior year.
- Cash from Operations for Q4 2025 stood at 10596000.0, down from 2957000.0 in the prior quarter.
- The five-year high for Cash from Operations was 2957000.0 in Q3 2025, with the low at 14038000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 106.85 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 122.94 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 97.53 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 43.08 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 109.52 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 84.91 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 26.12 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -49.47 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 54.50 Mn |
| 10 | Heartflow | 1.15 Bn | 974.90 Mn | 39.06 Mn | -10.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.60 Mn |
| Dec 31, 2025 | -10.60 Mn |
| Sep 30, 2025 | -2.96 Mn |
| Sep 30, 2025 | -2.96 Mn |
| Dec 31, 2024 | -14.04 Mn |
| Dec 31, 2024 | -14.04 Mn |
| Sep 30, 2024 | -10.27 Mn |
| Sep 30, 2024 | -10.27 Mn |